Roche

Basel, Switzerland Founded: 1896 • Age: 130 yrs
Pharmaceuticals and diagnostics kits are developed for various diseases.
Request Access

About Roche

Roche is a company based in Basel (Switzerland) founded in 1896. It operates as a HealthTech, and Professional Services. The company has 103,250 employees as of December 31, 2024. Roche has completed 50 acquisitions, including 454 Life Sciences, Adheron Therapeutics and Anadys Pharma. Roche offers products and services including Pharma Solutions, Diagnostic Solutions, and Susvimo. Roche operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.

  • Headquarter Basel, Switzerland
  • Employees 103250 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Roche Holding Ltd
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
    $66.77 B (USD)
    3.03
    as on Dec 31, 2024
  • Net Profit
    $9.14 B (USD)
    -28.01
    as on Dec 31, 2024
  • EBITDA
    $23.91 B (USD)
    9.28
    as on Dec 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    103250

    as on Dec 31, 2024

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Roche

Roche is a publicly listed company on the SIX with ticker symbol RO in Switzerland, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: SIX · Ticker: RO . Sector: Health technology · Switzerland

Products & Services of Roche

Roche offers a comprehensive portfolio of products and services, including Pharma Solutions, Diagnostic Solutions, and Susvimo. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Innovative medicines are developed to treat various diseases.

Advanced diagnostic tools are provided for accurate disease detection.

Continuous delivery treatment is offered for diabetic macular edema.

People of Roche
Headcount 10000+
Employee Profiles 432
Board Members and Advisors 10
Employee Profiles
People
Semyon Grigorchuk
Marketing Lead
People
Jessica Betts
Senior Regulatory Compliance Manager
People
Jake Butz
Legal Counsel
People
Dheeraj Manchanda
Head - Operations & Channel Management

Unlock access to complete

Board Members and Advisors
people
Paul Bulcke
Director
people
Claudia Suessmuth Dyckerhoff
Director
people
Richard P. Lifton
Director
people
André Hoffmann
Vice Chairman

Unlock access to complete

Funding Insights of Roche

  • Total Funding
  • Total Rounds 18
  • Last Round
  • First Round

    (01 May 2004)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2023 Amount Post-IPO - Roche Valuation

investors

Jun, 2022 Amount Grant - Roche Valuation

investors

Aug, 2021 Amount Post-IPO - Roche Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Roche

Roche has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include SoftBank Group, HHS and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Provides financial advisory, investment planning, retirement services, and trust management for clients.
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investments are directed toward multiple sectors via fund of funds.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Roche

Roche has strategically engaged in corporate development activities, having acquired 50 companies. Notable acquisitions include 454 Life Sciences, Adheron Therapeutics and Anadys Pharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Therapeutics for inflammatory and fibrotic diseases are developed.
2022
Provider of therapeutics related to oncology, autoimmune and metabolic disease
2018
Protein-based drugs for cancer treatment are developed.
2016
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Roche

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Roche Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Roche

Roche operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Pharmaceutical products are manufactured and marketed worldwide.
domain founded_year HQ Location
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
domain founded_year HQ Location
Biopharmaceutical research and drug development are conducted globally by AbbVie.
domain founded_year HQ Location
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
domain founded_year HQ Location
Traditional pharmaceutical medicines are developed for multiple health fields.
domain founded_year HQ Location
Developer of drugs for the treatment of multiple disorders
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Roche

Frequently Asked Questions about Roche

When was Roche founded?

Roche was founded in 1896 and raised its 1st funding round 108 years after it was founded.

Where is Roche located?

Roche is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.

Who is the current CEO of Roche?

Thomas Schinecker is the current CEO of Roche.

How many employees does Roche have?

As of Dec 31, 2024, the latest employee count at Roche is 103,250.

What is the annual revenue of Roche?

Annual revenue of Roche is $66.77B as on Dec 31, 2024.

What does Roche do?

Roche is engaged in the development of innovative medicines and diagnostic solutions to improve health outcomes. The company operates in the healthcare sector, addressing urgent challenges through pharmaceuticals and diagnostics. Solutions are provided to prevent, stop, and cure diseases by identifying high-risk patients, accurately diagnosing conditions, and delivering targeted treatments. Efforts are directed toward revolutionizing patient care with technologies like Brainshuttle for CNS disease treatment.

Who are the top competitors of Roche?

Roche's top competitors include Merck, Roivant Sciences and AbbVie.

What products or services does Roche offer?

Roche offers Pharma Solutions, Diagnostic Solutions, and Susvimo.

Is Roche publicly traded?

Yes, Roche is publicly traded on SIX under the ticker symbol RO.

How many acquisitions has Roche made?

Roche has made 50 acquisitions, including 454 Life Sciences, Adheron Therapeutics, and Anadys Pharma.

Who are Roche's investors?

Roche has 5 investors. Key investors include SoftBank Group, HHS, European Union, BAFA, and NHTrust.

What is Roche's ticker symbol?

The ticker symbol of Roche is RO on SIX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available